share_log

Jolt Health Inc. Announces Financing

Jolt Health Inc. Announces Financing

Jolt Health公司宣佈融資
Accesswire ·  07/26 05:00

VANCOUVER, BC / ACCESSWIRE / July 25, 2024 / Jolt Health Inc. ("JOLT" and or "the Company") (CSE:JOLT)(FSE:G1Q0) announced it is undertaking a non-brokered private placement of up to $500,000. The Company will issue up to 583,333,333 units at a price of $0.006 per unit. Each unit consists of one common share and one half of a common share warrant. Each whole warrant entitles the holder to subscribe for one additional common share for a period of 2 years from the date of closing at a price of $0.05, subject to the Corporation's option to accelerate the expiry date if the stock trades at $0.15 for 10 trading days.

JOLT Health Inc.(“JOLT”或“公司”)(CSE:JOLT)(FSE:G1Q0)宣佈將進行非經紀人定向增發,金額最高達到$ 500,000。公司將以0.006美元的價格發行最多583,333,333個單位。每個單位包括一種普通股和半種普通股認股權證,每個完整的權證可使持有人在2年內以0.05美元的價格認購另一種普通股,但主體有權提前到期,如果股票在10個交易日內達到0.15美元,則產品交易期滿。

It is anticipated that certain insiders will participate in this financing. The Company is relying on various exemptions contained in NI 61-101 in respect to the valuation and minority approval requirements in related party transactions.

公司預期特定內部人士將參加這次融資。公司依賴於NI 61-101中包含的各種豁免條款,以滿足有關方交易中估值和少數股東批准要求。

Jolt intends to use the net proceeds of the Offering for general working capital.

Jolt擬使用籌集的淨收益用作一般營運資金。

About Jolt Health Inc.

關於Jolt Health Inc.

Jolt Health Inc. (CSE - JOLT) is a leading life sciences company focused on healthcare, biotechnology and artificial intelligence. The company currently holds exclusive licenses for innovative therapeutic and pharmaceutical products throughout Europe, the UK, and North America. The company is committed to transforming the industry through research, collaboration, and technological advancement, sharping the future of healthcare worldwide.

Jolt Health Inc.(CSE-JOLT)是一家專注於醫療保健,生物技術和人工智能領域的領先生命科學公司。該公司目前持有歐洲,英國和北美的創新治療和藥品的獨家許可證。該公司致力於通過研究,協作和技術進步來改變行業,塑造全球醫療保健的未來。

For further information, please contact:

如需更多信息,請聯繫:

Gerald Tritt, CEO
Investor Relations
Telephone: 1 (604) 343-2977
E-mail: info@jolt-health.com

傑拉爾德·特里特,首席執行官
投資者關係
電話:1 (604) 343-2977
電子郵件:info@jolt-health.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

加拿大證券交易所及其監管服務提供商(如該術語在加拿大證券交易所的政策中定義)均不承擔對本公告之充分性或準確性的責任。

Forward Looking Statements

前瞻性聲明

Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. All statements other than statements of historical fact are forward-looking statements, including, without limitation, statements regarding future financial position, business strategy, use of proceeds, corporate vision, proposed acquisitions, partnerships, joint-ventures and strategic alliances and co-operations, budgets, cost and plans and objectives of or involving the Company. Such forward-looking information reflects management's current beliefs and is based on information currently available to management. Often, but not always, forward-looking statements can be identified by the use of words such as "plans", "expects", "is expected", "budget", "scheduled", "estimates", "forecasts", "predicts", "intends", "targets", "aims", "anticipates", "may" or "believes" or variations (including negative variations) of such words and phrases or may be identified by statements to the effect that certain actions "may", "could", "should", "would", "might" or "will" be taken, occur or be achieved. A number of known and unknown risks, uncertainties and other factors may cause the actual results or performance to materially differ from any future results or performance expressed or implied by the forward-looking information. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of the Company including, but not limited to, the impact of general economic conditions, industry conditions, risks relating to epidemics or pandemics such as COVID-19, including the impact of COVID-19 on the Company's business, financial condition and results of operations, lack of investor demand for Bitcoin and/or Bitcoin futures exchange traded funds, and dependence upon regulatory approvals. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company does not assume any obligation to update or revise its forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by securities laws.

本新聞稿中列出的某些信息可能含有前瞻性聲明,這些聲明涉及嚴重已知和未知的風險和不確定性。所有陳述除了歷史事實陳述之外,均爲前瞻性陳述,包括但不限於關於未來財務狀況,業務策略,使用財務收益,企業願景,擬議收購,合作伙伴關係,合資企業和戰略聯盟和合作,預算,成本和計劃以及有關公司的目標的陳述。這種前瞻性信息反映了管理層當前的信仰,並基於管理層當前可用的信息。通常情況下,但並非總是,前瞻性陳述可通過使用諸如“計劃”,“預期”,“預計”,“預算”,“安排”,“估計”,“預測”,“打算”,“目標”,“瞄準”,“預測”,“意圖”, “可能”或“相信”或此類詞語和短語的變體(包括負面變體)來識別,或者可以通過這樣的聲明來識別,即某些行動“可能”,“可能”,“應該”,“將”,“可能”或“將”被採取,發生或實現。許多已知和未知的風險,不確定性和其他因素可能會導致某些明顯的事實結果或表現與其與前瞻性信息所表達的任何未來結果或應有表現實質不同。這些前瞻性陳述可能面臨多種風險和不確定性,其中一些風險和不確定性超出公司的控制範圍,包括但不限於一般經濟狀況的影響,行業狀況,涉及疫情或流行病(例如COVID-19)的風險,COVID-19對公司業務,財務狀況和業績的影響,對比特幣和/或比特幣期貨交易所交易基金的投資者需求不足以及依賴監管批准。讀者應當注意,在準備此類信息時使用的假設,雖然在準備時被視爲合理,但可能被證明是不準確的,因此不應過度依賴前瞻性陳述。除非根據證券法律規定,否則公司不承擔更新或修訂其前瞻性陳述的任何義務,無論是因爲新信息,未來事件還是其他原因。

SOURCE: Jolt Health Inc.

來源:Jolt Health Inc.


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論